In Vivo is part of Pharma Intelligence UK Limited

This site is operated by Pharma Intelligence UK Limited, a company registered in England and Wales with company number 13787459 whose registered office is 5 Howick Place, London SW1P 1WG. The Pharma Intelligence group is owned by Caerus Topco S.à r.l. and all copyright resides with the group.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction

Sinopharm Kicks Off National Emergency Allocation System For Medical Reserves

This article was originally published in PharmAsia News

Executive Summary

On the instruction of the National Development and Reform Commission, China National Pharmaceutical Group Corporation (Sinopharm) has shipped the first batch of ventilators, ECG monitors, surgical instruments and transfusion equipment to earthquake-hit regions in Sichuan. Responsible for national medical reserves, Sinopharm has set up an emergency allocation system and a group leading rescue efforts. All subsidiaries involved in the exercise are tasked to ensure the specifications and quantity of medical reserves correspond to NDRC's predetermined catalog, as well as make emergency procurement of necessary medicines and devices outside the catalog. Logistics centers in Beijing, Shanghai and Tianjin and major warehouses have been notified to stand by for medical allocation assignments at a moment's notice. (Click here for more - Chinese Language)

Latest Headlines
See All
UsernamePublicRestriction

Register

SC068500

Ask The Analyst

Ask the Analyst is free for subscribers.  Submit your question and one of our analysts will be in touch.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel